These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8100197)

  • 1. The dopamine D1 receptor agonists, A68930 and SKF 38393, induce arousal and suppress REM sleep in the rat.
    Trampus M; Ferri N; Adami M; Ongini E
    Eur J Pharmacol; 1993 Apr; 235(1):83-7. PubMed ID: 8100197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dopamine D1 receptor is involved in the regulation of REM sleep in the rat.
    Trampus M; Ferri N; Monopoli A; Ongini E
    Eur J Pharmacol; 1991 Mar; 194(2-3):189-94. PubMed ID: 2060599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sleep during acute dopamine D1 agonist SKF 38393 or D1 antagonist SCH 23390 administration in rats.
    Monti JM; Fernández M; Jantos H
    Neuropsychopharmacology; 1990 Jun; 3(3):153-62. PubMed ID: 2141985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A68930 is a potent, full agonist at dopamine1 (D1) receptors in renal epithelial LLC-PK1 cells.
    Grenader A; Healy DP
    Br J Pharmacol; 1992 Jun; 106(2):229-30. PubMed ID: 1356555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine D1 receptor agonist-induced grooming is blocked by the opioid receptor antagonist naloxone.
    Stoessl AJ
    Eur J Pharmacol; 1994 Jul; 259(3):301-3. PubMed ID: 7982457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the D1-dopamine agonists SKF-38393 and A-68930 in neonatal 6-hydroxydopamine-lesioned rats: behavioral effects and induction of c-fos-like immunoreactivity.
    Johnson KB; Criswell HE; Jensen KF; Simson PE; Mueller RA; Breese GR
    J Pharmacol Exp Ther; 1992 Aug; 262(2):855-65. PubMed ID: 1354257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed suppressive effect of a low dose of caerulein on the grooming behavior induced by the D1-receptor agonist SKF 38393.
    Masuda Y; Murai S; Saito H; Abe E; Itoh T
    Jpn J Pharmacol; 1992 Oct; 60(2):141-4. PubMed ID: 1362232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid reversal of denervation supersensitivity of dopamine D1 receptors by l-dopa or a novel dopamine D1 receptor agonist, A68930.
    Britton DR; Kebabian JW; Curzon P
    Eur J Pharmacol; 1991 Jul; 200(1):89-93. PubMed ID: 1685124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of a delta opioid receptor agonist but not a mu opioid receptor agonist with the D1-selective dopamine receptor agonist SKF 38393 markedly potentiates different behaviors in mice.
    Toyoshi T; Ukai M; Kameyama T
    Eur J Pharmacol; 1992 Mar; 213(1):25-30. PubMed ID: 1354161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of D1 dopamine receptor agonists on oral ethanol self-administration in rats: comparison with their efficacy to produce grooming and hyperactivity.
    Cohen C; Perrault G; Sanger DJ
    Psychopharmacology (Berl); 1999 Feb; 142(1):102-10. PubMed ID: 10102789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the selective dopamine D-2 receptor agonist, quinpirole on sleep and wakefulness in the rat.
    Monti JM; Jantos H; Fernández M
    Eur J Pharmacol; 1989 Oct; 169(1):61-6. PubMed ID: 2574689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theophylline-induced grooming: possible indirect dopaminergic mechanism.
    Zarrindast MR; Sharifzadeh M; Sadeghi AI
    Eur J Pharmacol; 1996 Jun; 306(1-3):1-4. PubMed ID: 8813608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine D1 receptor involvement in the discriminative-stimulus effects of SKF 81297 in squirrel monkeys.
    Rosenzweig-Lipson S; Bergman J
    J Pharmacol Exp Ther; 1993 Nov; 267(2):765-75. PubMed ID: 7902432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Super-stereotypy II: enhancement of a complex movement sequence by intraventricular dopamine D1 agonists.
    Berridge KC; Aldridge JW
    Synapse; 2000 Sep; 37(3):205-15. PubMed ID: 10881042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A68930: a potent agonist selective for the dopamine D1 receptor.
    DeNinno MP; Schoenleber R; MacKenzie R; Britton DR; Asin KE; Briggs C; Trugman JM; Ackerman M; Artman L; Bednarz L
    Eur J Pharmacol; 1991 Jun; 199(2):209-19. PubMed ID: 1683288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidepressant-like effect of selective dopamine D1 receptor agonists in the behavioural despair animal model of depression.
    D'Aquila PS; Collu M; Pani L; Gessa GL; Serra G
    Eur J Pharmacol; 1994 Sep; 262(1-2):107-11. PubMed ID: 7813561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Super-stereotypy I: enhancement of a complex movement sequence by systemic dopamine D1 agonists.
    Berridge KC; Aldridge JW
    Synapse; 2000 Sep; 37(3):194-204. PubMed ID: 10881041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine D1 receptor stimulation increases striatal acetylcholine release in the rat.
    Damsma G; Tham CS; Robertson GS; Fibiger HC
    Eur J Pharmacol; 1990 Sep; 186(2-3):335-8. PubMed ID: 1981190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anatomical localization of SKF-38393-induced behaviors in rats using the irreversible monoamine receptor antagonist EEDQ.
    Neisewander JL; Ong A; McGonigle P
    Synapse; 1995 Feb; 19(2):134-43. PubMed ID: 7725242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of antidepressant drugs and different receptor antagonists on the grooming induced by the dopamine D-1 agonist SKF 38393.
    Skuza G; Rogóz Z; Zak J
    Pol J Pharmacol Pharm; 1989; 41(5):421-9. PubMed ID: 2577061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.